Lunit to Present Six AI Studies at AACR 2026 Highlighting Advances in Precision Oncology and Real-World Clinical Application [Yahoo! Finance]
Agilent Showcases Cancer Research Solutions at AACR 2026
Agilent Technologies (A) had its price target lowered by Barclays PLC from $150.00 to $140.00. They now have an "overweight" rating on the stock.
How Investors May Respond To Agilent Technologies (A) CRISPR Patent Setback And New BioTek Cytation 9 Launch [Yahoo! Finance]
Synthego Welcomes Supreme Court Order Finalizing Invalidation of Agilent CRISPR Patents [Yahoo! Finance]